Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 305

1.

Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery.

Banerjee S, Angiolillo DJ, Boden WE, Murphy JG, Khalili H, Hasan AA, Harrington RA, Rao SV.

J Am Coll Cardiol. 2017 Apr 11;69(14):1861-1870. doi: 10.1016/j.jacc.2017.02.012. Review.

PMID:
28385315
2.

Antianginal Therapy for Stable Ischemic Heart Disease.

Padala SK, Lavelle MP, Sidhu MS, Cabral KP, Morrone D, Boden WE, Toth PP.

J Cardiovasc Pharmacol Ther. 2017 Jan 1:1074248417698224. doi: 10.1177/1074248417698224. [Epub ahead of print]

PMID:
28361599
3.

Role of Imaging in the Management of Stable Ischemic Heart Disease: An Evolving Paradigm Shift.

Boden WE, Meadows JL.

JACC Cardiovasc Imaging. 2017 Mar;10(3):335-337. doi: 10.1016/j.jcmg.2016.12.009. No abstract available.

PMID:
28279381
4.

Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review.

Mathew RO, Bangalore S, Lavelle MP, Pellikka PA, Sidhu MS, Boden WE, Asif A.

Kidney Int. 2017 Apr;91(4):797-807. doi: 10.1016/j.kint.2016.09.049. Epub 2016 Dec 28. Review.

PMID:
28040264
5.

Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.

Mancini GB, Farkouh ME, Brooks MM, Chaitman BR, Boden WE, Vlachos H, Hartigan PM, Siami FS, Sidhu MS, Bittner V, Frye R, Fuster V.

J Am Coll Cardiol. 2016 Sep 6;68(10):985-95. doi: 10.1016/j.jacc.2016.06.021.

PMID:
27585501
6.

Should Beta-Blockers Continue to Be Used in Post-Percutaneous Coronary Intervention Patients Without Myocardial Infarction?

Nappi AG, Boden WE.

JACC Cardiovasc Interv. 2016 Aug 22;9(16):1649-51. doi: 10.1016/j.jcin.2016.07.001. No abstract available.

PMID:
27539684
7.

Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial.

Kaul P, Ohman EM, Knight JD, Anstrom KJ, Roe MT, Boden WE, Hochman JS, Gašparović V, Armstrong PW, McCollam P, Fakhouri W, Cowper P, Davidson-Ray L, Clapp-Channing N, White HD, Fox KA, Prabhakaran D, Mark DB; TRILOGY ACS Investigators..

Am Heart J. 2016 Aug;178:55-64. doi: 10.1016/j.ahj.2016.03.017. Epub 2016 Apr 16.

PMID:
27502852
8.

Predictors of Initial Revascularization Versus Medical Therapy Alone in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing an Invasive Strategy.

Wijeysundera HC, Sidhu MS, Bennell MC, Qiu F, Ko DT, Knudtson ML, Tu JV, Boden WE.

Circ Cardiovasc Interv. 2016 Jul;9(7). pii: e003592. doi: 10.1161/CIRCINTERVENTIONS.115.003592.

PMID:
27418612
9.

Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease.

Weintraub WS, Boden WE.

JAMA Intern Med. 2016 Aug 1;176(8):1190-4. doi: 10.1001/jamainternmed.2016.3071.

PMID:
27380178
10.

Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With Diabetes.

Asleh R, Levy NS, Doros G, Costacou T, Robinson JG, Blum S, Goldenstein H, Boden WE, Simmons DL, Lacy MA, Grunberger G, Anderson TJ, Levy AP.

J Am Coll Cardiol. 2016 May 31;67(21):2553-4. doi: 10.1016/j.jacc.2016.03.533. No abstract available.

PMID:
27230052
11.

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.

Hagström E, Roe MT, Hafley G, Neely ML, Sidhu MS, Winters KJ, Prabhakaran D, White HD, Armstrong PW, Fox KA, Ohman EM, Boden WE; TRILOGY ACS Investigators..

Clin Cardiol. 2016 Jun;39(6):329-37. doi: 10.1002/clc.22533. Epub 2016 May 13.

12.

A PROMISE Fulfilled That Quality-of-Life Assessments Afford Incremental Value to Coronary Artery Disease Management.

Schulman-Marcus J, Boden WE.

Circulation. 2016 May 24;133(21):1989-91. doi: 10.1161/CIRCULATIONAHA.116.022732. Epub 2016 Apr 27. No abstract available.

PMID:
27143677
13.

Does Physiology Trump Anatomy as the "Best Course" to Guide PCI Decision Making and Outcomes?

Nappi AG, Boden WE.

J Am Coll Cardiol. 2016 Apr 12;67(14):1712-4. doi: 10.1016/j.jacc.2016.01.057. No abstract available.

14.

Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.

Goldberg RB, Bittner VA, Dunbar RL, Fleg JL, Grunberger G, Guyton JR, Leiter LA, McBride R, Robinson JG, Simmons DL, Wysham C, Xu P, Boden WE.

Am J Med. 2016 Jul;129(7):753.e13-22. doi: 10.1016/j.amjmed.2016.02.039. Epub 2016 Mar 29.

PMID:
27036394
15.

Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients.

Chin CT, Boden WE, Roe MT, Neely B, Neely ML, Leiva-Pons JL, Corbalán R, Gottlieb S, Dalby AJ, Armstrong PW, Prabhakaran D, Fox KA, White HD, Ohman EM, Winters KJ, Schiele F.

Heart. 2016 Aug 1;102(15):1221-9. doi: 10.1136/heartjnl-2015-308840. Epub 2016 Mar 30.

PMID:
27030601
16.

Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.

Acharjee S, Teo KK, Jacobs AK, Hartigan PM, Barn K, Gosselin G, Tanguay JF, Maron DJ, Kostuk WJ, Chaitman BR, Mancini GB, Spertus JA, Dada MR, Bates ER, Booth DC, Weintraub WS, O'Rourke RA, Boden WE; COURAGE Trial Research Group..

Am Heart J. 2016 Mar;173:108-17. doi: 10.1016/j.ahj.2015.07.020. Epub 2015 Jul 26.

PMID:
26920603
17.

A Novel Diagnostic Approach for Evaluating Suspected Coronary Artery Disease.

Boden WE.

Am J Med. 2016 Jun;129(6):557-9. doi: 10.1016/j.amjmed.2016.01.023. Epub 2016 Feb 1. No abstract available.

PMID:
26836388
18.

CABG for Complex CAD: When Will Evidence-Based Practice Align With Evidence-Based Medicine?

Boden WE, Mancini GB.

J Am Coll Cardiol. 2016 Jan 5;67(1):56-8. doi: 10.1016/j.jacc.2015.11.004. No abstract available.

19.

Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?

Cheng-Torres KA, Desai KP, Sidhu MS, Maron DJ, Boden WE.

Future Cardiol. 2016 Jan;12(1):35-44. doi: 10.2217/fca.15.57. Epub 2015 Dec 21.

PMID:
26696561
20.

Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.

Stone GW, Hochman JS, Williams DO, Boden WE, Ferguson TB Jr, Harrington RA, Maron DJ.

J Am Coll Cardiol. 2016 Jan 5;67(1):81-99. doi: 10.1016/j.jacc.2015.09.056. Epub 2015 Nov 23. Review.

Supplemental Content

Loading ...
Support Center